Page results
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
File results
-
FOI/2021/0514 - Mental health patients in ED
-
FOI/2021/0515 - Trusts expenditure and estate
-
FOI/2021/0516 - Number of patients arriving at UCLH via ambulance
-
FOI/2021/0517 - Guideline/ Treatment pathway of Chronic Kidney Disease (CKD)
-
FOI/2021/0520 - Policy for gestational diabetes testing
-
FOI/2021/0521 - Policies and approach on the NHS Accessible Information Standard (AIS)
-
FOI/2021/0524 - Maternal death cases (2005 - 2015)
-
FOI/2021/0529 - Radiology department e-mail system for patients to reschedule appointments
-
FOI/2021/0531 - Neonatal care unit complaints over limited access due to Covid-19 restrictions
-
FOI/2021/0536 - PAT Testing